<code id='FA5E59FECE'></code><style id='FA5E59FECE'></style>
    • <acronym id='FA5E59FECE'></acronym>
      <center id='FA5E59FECE'><center id='FA5E59FECE'><tfoot id='FA5E59FECE'></tfoot></center><abbr id='FA5E59FECE'><dir id='FA5E59FECE'><tfoot id='FA5E59FECE'></tfoot><noframes id='FA5E59FECE'>

    • <optgroup id='FA5E59FECE'><strike id='FA5E59FECE'><sup id='FA5E59FECE'></sup></strike><code id='FA5E59FECE'></code></optgroup>
        1. <b id='FA5E59FECE'><label id='FA5E59FECE'><select id='FA5E59FECE'><dt id='FA5E59FECE'><span id='FA5E59FECE'></span></dt></select></label></b><u id='FA5E59FECE'></u>
          <i id='FA5E59FECE'><strike id='FA5E59FECE'><tt id='FA5E59FECE'><pre id='FA5E59FECE'></pre></tt></strike></i>

          entertainment

          entertainment

          author:Wikipedia    Page View:1269
          Commuters wearing face masks walk along a pedestrian bridge during the evening rush hour in Beijing -- health coverage from STAT
          Mark Schiefelbein/AP

          Northeastern University has been selected for a leading role in a new national network formed to better forecast the spread of a future pandemic.

          The university announced Tuesday the US Centers for Disease Control and Prevention has awarded it $17.5 million over the next five years to develop a center focused on detecting and preparing for the next outbreak of infectious disease, especially in rural areas.

          advertisement

          Alessandro Vespignani, director of Northeastern’s Network Science Institute, is leading the project, called “EPISTORM: The Center for Advanced Epidemic Analytics and Predictive Modeling Technology.”

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          knowledge

          Medical records are filled with copy
          Medical records are filled with copy

          AdobeIrecentlytookcareofapatientwhosemedicalrecordsincludedmultiplenotesaboutherpastopen-heartsurger

          read more
          Duchenne drug from Nippon Shinyaku fails in rare confirmatory trial
          Duchenne drug from Nippon Shinyaku fails in rare confirmatory trial

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCJapanesedrugmakerNipponShinyakusaidon

          read more
          George Santos makes 1st court appearance after pleading not guilty to 13 counts
          George Santos makes 1st court appearance after pleading not guilty to 13 counts

          1:57GeorgeSantosarrivesatfederalcourtJune30,2023,inCentralIslip,N.Y.JohnMinchillo/APRep.GeorgeSantos

          read more

          An innovative path out of biotech’s “valley of death”

          AdobeSomanypromisingmedicalinnovationsneverreachtheirfullpotentialastherapiesorcures,languishinginst